Literature DB >> 23680490

Inhibition of phagocytosis and lysosomal acidification suppresses neurotoxic prion peptide-induced NALP3 inflammasome activation in BV2 microglia.

Fushan Shi1, Yang Yang, Mohammed Kouadir, Yongyao Fu, Lifeng Yang, Xiangmei Zhou, Xiaomin Yin, Deming Zhao.   

Abstract

Prion diseases are neurodegenerative disorders characterized by the accumulation of misfolded prion protein. In a previous study, we showed that neurotoxic prion peptide (PrP106-126) induced NALP3 inflammasome activation in mouse primary and immortalized microglia. In the present work, we examined the relevance of phagocytosis and lysosomal acidification to the activation of the NALP3 inflammasome in PrP106-126-stimulated microglia. Our results showed that the inhibition of phagocytosis or lysosomal acidification significantly reduced IL-1β and IL-18 production, downregulated NALP3 and ASC expression, and decreased the expression of proinflammatory factors. We concluded that phagocytosis and lysosomal acidification are necessary for PrP106-126-induced NALP3 activation in BV2 cells.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23680490     DOI: 10.1016/j.jneuroim.2013.04.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

Review 1.  Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.

Authors:  Juan Pablo de Rivero Vaccari; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

Review 2.  Pattern recognition receptors and central nervous system repair.

Authors:  Kristina A Kigerl; Juan Pablo de Rivero Vaccari; W Dalton Dietrich; Phillip G Popovich; Robert W Keane
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

3.  Inflammasome in drug abuse.

Authors:  Enquan Xu; Jianuo Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

4.  Prion pathogenesis in the absence of NLRP3/ASC inflammasomes.

Authors:  Mario Nuvolone; Silvia Sorce; Petra Schwarz; Adriano Aguzzi
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

5.  Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia.

Authors:  Ji-Yun Kim; James C Paton; David E Briles; Dong-Kwon Rhee; Suhkneung Pyo
Journal:  Oncotarget       Date:  2015-12-29

Review 6.  Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.

Authors:  Yang Yang; Huanan Wang; Mohammed Kouadir; Houhui Song; Fushan Shi
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

Review 7.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

8.  Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.

Authors:  Yi Liu; Run Zhang; Ke Yan; Fanfan Chen; Weiyi Huang; Bingke Lv; Chengmei Sun; Limin Xu; Feng Li; Xiaodan Jiang
Journal:  J Neuroinflammation       Date:  2014-08-04       Impact factor: 8.322

9.  Protecting cells by protecting their vulnerable lysosomes: Identification of a new mechanism for preserving lysosomal functional integrity upon oxidative stress.

Authors:  Raquel Pascua-Maestro; Sergio Diez-Hermano; Concepción Lillo; Maria D Ganfornina; Diego Sanchez
Journal:  PLoS Genet       Date:  2017-02-09       Impact factor: 5.917

10.  The NLRP3-Caspase 1 Inflammasome Negatively Regulates Autophagy via TLR4-TRIF in Prion Peptide-Infected Microglia.

Authors:  Mengyu Lai; Hao Yao; Syed Zahid Ali Shah; Wei Wu; Di Wang; Ying Zhao; Lu Wang; Xiangmei Zhou; Deming Zhao; Lifeng Yang
Journal:  Front Aging Neurosci       Date:  2018-04-18       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.